Hamster one-cell embryos were collected from two groups of donors: females that were super-stimulated with pregnant mare's serum gonadotrophin (PMSG) and females that were not. Embryos were cultured for 72 h and scored for development. Morulae and blastocysts from the PMSGand non-stimulated females were transferred into contralateral uterine horns of non-stimulated recipient females, so that experimental embryos (from PMSG-stimulated females) and control embryos (from non-stimulated females) were paired within a single recipient. Right and left uterine horns of recipient females were examined 11 days later for the number of implantation sites and fetuses. After 72 h of culture, development to morulae and blastocysts was not significantly different for embryos from PMSG-and non-stimulated females. However, embryos from PMSG-stimulated females compared to controls had significantly reduced mean cell numbers (18 versus 21; P⍧0.003) and a two-fold decrease in viability post-transfer (20 versus 45%; P⍧0.02). These findings indicate that gonadotrophin stimulation compromises subsequent developmental competence either during oocyte maturation or in the very early embryo, but it is unclear whether reduced viability is a direct effect or is an indirect consequence of PMSG stimulation.
Introduction
The mammalian oestrous cycle is regulated by the interplay of reproductive hormones originating from the hypothalamus (releasing hormone), the pituitary [follicle stimulating hormone (FSH) and luteinizing hormone (LH)] and the ovary (oestrogen and progesterone). These hormones are necessary for follicular maturation, ovulation, implantation and maintenance of gestation (Hafez, 1987) . Manipulation of these hormones has advanced the development of contraceptive technologies as well as treatments for infertility, production of valuable livestock and the understanding of basic reproductive physiology.
One specific application of reproductive hormone manipulation has been the use of supra-physiological dosages of FSH to increase the number of eggs recruited for ovulation in a single cycle. Either eggs or embryos are then collected for fertilization and/or development in vitro. Embryos may be transferred back to the same or a recipient female for producing offspring. These procedures have been very successful in producing large numbers of eggs or embryos; however, a relatively low number of live offspring result (Walton et al., 1982; King, 1985; Vanderhyden and Armstrong, 1988; Katagiri et al., 1996) .
In mice, rats and hamsters, which have been used for the majority of studies on oocytes and embryos, pregnant mare's serum gonadotrophin (PMSG) is most often used to induce multiple ovulations from the ovary for increased egg production. This commercial preparation is relatively inexpensive and effective in producing numbers of hamster oocytes (40-60) considerably greater than those normally produced in a single cycle (8-14 oocytes) . In most hamster studies from this laboratory and in numerous studies from other laboratories, it is tacitly assumed that eggs and embryos collected and cultured from PMSG-stimulated females are 'normal'. However, there is increasing evidence that these eggs and embryos or the environment in which they reside may be different from their non-stimulated counterparts.
FSH is normally released into the bloodstream in small amounts. The introduction of high circulating levels of FSH significantly affects the target organ (the ovary), with downstream effects on the oviduct and uterus due to increased oestrogen and progesterone secretion. A disruption in the hormone profile (Walton et al., 1983; Leveille and Armstrong, 1989) may create a follicular, oviductal or uterine environment hostile to developing eggs, embryos and/or fetuses (Miller and Armstrong, 1981a,b; Walton and Armstrong, 1981; Walton et al., 1982; Ertzeid et al., 1993; Paulson et al., 1997) . High doses of FSH may have a direct effect on oocyte quality such as the ability to be fertilized (Walton et al., 1983; Evans and Armstrong, 1984; Moor et al., 1985) , impaired development (Lehtonen and Kankondi, 1987; Ertzeid and Storeng, 1992; Ertzeid et al., 1993) and/or chromosomal anomalies (Maudlin and Fraser, 1977; King, 1985; Luckett and Mukherjee, 1986; Wojcik et al., 1995) .
This study focused on the effect of PMSG stimulation alone (no human chorionic gonadotrophin was administered) on hamster pre-implantation embryo development in vitro followed by embryo transfer and fetal development, compared to culture and transfer of embryos collected from non-stimulated females. One-cell embryos were isolated from the reproductive tract of the stimulated female thereby limiting the effects of PMSG to the follicle and a brief oviductal exposure. This was a controlled, in-vitro development study with paired treatment groups (embryos from stimulated and non-stimulated donors) examining both morphological development and embryonic cell numbers. In addition, because pre-implantation Bavister and Andrews, 1988 ) and stored at 4°C for no more than 3 days prior to an experiment. b Amino acids were prepared as a ϫ100 stock and added to the basic medium the day of the experiment (McKiernan et al., 1995) . c PVA (polyvinyl alcohol); Sigma Chemical Co., St. Louis, MO, USA.
embryo morphology does not directly correlate with fetal viability (McKiernan and Bavister, 1994) , post-transfer viability was assessed. In the golden hamster there are two uteri, each with its own cervix opening separately into the vagina, so that embryos do not migrate between the two sides (Magalhaes, 1968) . The cultured embryos from PMSG-and non-stimulated females were transferred to contralateral uterine horns of the same recipient female to compare post-implantation development.
Materials and methods

Animals
Hamsters were maintained on a 14 h light:10 h dark photoperiod. Mature females were examined daily for post-oestrus discharge to define day 1 of the cycle (Orsini, 1961) . Over the course of the experiment, 31 female hamsters were stimulated with a single i.p. injection of PMSG before 1000 h on the day of post-oestrus discharge. The PMSG dosage was weight dependent: female hamsters weighing 85-110 g received 10 IU, 111-135 g received 15 IU, 136-160 g, 20 IU and 161-185 g, 25 IU. Most animals used in this study were 3-4 months of age and weighed between 111 and 135 g; therefore, the average PMSG dosage was 15 IU per animal. The same number of females (31) of similar age and weight was selected, but not stimulated with PMSG. No human chorionic gonadotrophin (HCG) was administered (Bavister et al., 1983) . Both groups were mated to fertile males on the evening of day 4. At 1400 h on the following day, 10 h post-egg activation (Bavister et al., 1983) , pronucleate onecell embryos were collected from both PMSG-stimulated and nonstimulated females. Two to three pairs of females were used per replicate, and a total of 11 replicate experiments was performed.
Embryo culture
One-cell embryos that had two polar bodies and two pronuclei, as visualized at ϫ20 magnification, were collected from both groups of females. A total of 384 one-cell embryos was collected from 31 nonstimulated females (average of 12 per female) and 1488 one-cell embryos from PMSG-stimulated females (average of 48 per female). Embryos (n ϭ 381) collected from non-stimulated females were cultured in 50 µl drops of hamster embryo culture medium-6 (HECM-6, (McKiernan et al., 1995) . A similar number of embryos (n ϭ 383) from matching PMSG-stimulated females was cultured in adjacent drops. The number of embryos cultured per drop (mean n ϭ 12) was limited to the number of embryos collected from the non-stimulated females. Surplus embryos from PMSG-stimulated females were used in another study. Embryos were examined after 48 h of culture (58 h post-egg activation) for development to the eight-cell stage (McKiernan and Bavister, 1994 ) and again at 72 h for development to the morula and blastocyst stages, when cultures were terminated. A total of 11 replicate experiments was performed.
Embryo nuclei counts
Embryos from the first four replicates were fixed and stained to determine their nuclear numbers. After 72 h of culture, embryos from these four replicates were placed in 50 µl drops of 1% formalin in phosphate buffered saline (PBS) and stored at 4°C for not longer than 1 month. Nuclei were stained with Hoechst 33342 using a procedure modified from Boatman et al. (1988) . Briefly, embryos were rinsed in PBS and placed on a siliconized glass slide within a small circle enscribed on the underside of the slide. PBS was removed leaving the embryos on the slide within the circle. Then 5 µl of Hoechst working solution (30 µl of 1 mg Hoechst per 1 ml water ϩ 0.75 ml 2.3% Na citrate ϩ 0.25 ml 95% EtOH) was placed over the embryos. The slide was put on a slide warmer (37°C) and covered to prevent light exposure for 3 min, then the Hoechst solution was removed. A 25 µl drop of mounting medium (100 mg n-propyl gallate ϩ 0.5 ml Na citrate ϩ 4.5 ml glycerol) was placed on the slide and a coverslip was laid over the embryos. Nuclei were counted using a Nikon Diaphot inverted microscope equipped with an ultraviolet light source and a ϫ40 fluorescence objective.
Embryo transfer
Embryos from seven replicates were examined for development at 48 h of culture and again at 72 h before transfer to pseudopregnant recipient females. Recipient females, 3-5 months of age, were mated to vasectomized males on the day the experimental embryos were collected and put into culture (-1 day asynchronous). Taking advantage of the separate uteri in the hamster (Magalhaes, 1968) , morulae and blastocysts (cultured for 72 h from the one-cell stage) from both PMSG-and non-stimulated females were transferred to contralateral uterine horns of the same pseudopregnant female. The criterion for selection was that the number of morulae and blastocysts (embryos from the stimulated females) transferred to one uterine horn was identical to the number and morphology of morulae and blastocysts (embryos from the non-stimulated females) transferred to the contralateral uterine horn. Both morulae and blastocysts were transferred because embryos appearing to be morulae can in fact be collapsed blastocysts, since blastocysts undergo cycles of expansion and collapse in culture (McKiernan and Bavister, 1994) . Recipient females were anaesthetized with 1.0 mg/100 g body weight xylazine (Rompun, Phoenix Scientific Inc., St Joseph, MO, USA) and 20 mg/100 g body weight ketamine (Ketaset, Phoenix Scientific Inc.) (Barnett and Bavister, 1992) . A paralumbar incision was made on the dorsal surface of the recipient female. The upper one-third of each uterine horn was pulled through the incision. Embryos were transferred to the uterine lumen with a finely drawn, fire-polished Pasteur pipette, through a small puncture made with a 26 g needle. Approximately 16-20 embryos were transferred per recipient (eight to 10 embryos from each of the two treatment groups per uterine horn). Control embryo transfer experiments have shown that after transfer of 20 blastocysts, up to 17 viable fetuses are recoverable. After embryo transfer, the reproductive tract was replaced in the abdominal cavity and the body wall incision was closed using sutures and wound clips (McKiernan and Bavister, 1994) . Recipient females were examined on day 14 of pregnancy (day 11 after transfer, 2 days before parturition). Right and left uterine horns were exposed, fetuses were collected and resorption sites were recorded. Fetal weights were also recorded.
Statistical analysis
Percent embryo development (derived from total number of embryos cultured), mean nuclear numbers and embryo transfer results first underwent an arcsin transformation and were then analysed using two-sample t-tests (PϽ 0.05).
Results
A significantly higher percentage of embryos from PMSGstimulated females remained at the one-cell stage (3%) compared to embryos from non-stimulated females (0.2%). However, embryos collected from PMSG-stimulated females and non-stimulated females, once past the one-cell stage, had very similar developmental potential in vitro. There was no significant difference (P Ͼ 0.2) between treatments for the remaining levels of development analysed (Table II) .
At 82 h post-egg activation (72 h of culture), the mean nuclei numbers (Table III) of embryos developing from PMSGstimulated females (17 Ϯ 1) were significantly lower than the mean nuclei numbers of embryos from non-stimulated females (19 Ϯ 1; P Ͻ 0.05). Examination of the mean nuclear number of embryos that had more than eight cells showed a more pronounced difference between PMSG-stimulated (18 Ϯ 1) and non-stimulated (21 Ϯ 1; P Ͻ 0.01).
Post-implantation development of PMSG-and non-stimulated hamster embryos was assessed. Embryo transfers were performed on 14 pseudopregnant recipient female hamsters, of which 11 maintained pregnancy (79%). Counting only pregnant females, a total of 104 morulae and blastocysts from PMSG-stimulated donors produced 36 implantation sites (fetuses plus resorption sites) (36 Ϯ 9%, mean percentage from 11 recipient females) compared to 59 implantation sites (57 Ϯ 5%, mean percentage) out of 104 morulae and blastocysts from non-stimulated donors (Table IV) . These values were not significantly different (P ϭ 0.06). However, the number of viable fetuses produced from embryos of PMSGstimulated donors (20, 20 Ϯ 7%) was significantly lower than the number of fetuses produced from embryos of nonstimulated donors (47, 45 Ϯ 7%; P ϭ 0.02). In addition, the mean percentage of viable fetuses produced per implantation site was significantly lower from PMSG-stimulated embryos (36 Ϯ 11%) than from non-stimulated embryos (74 Ϯ 9%; P ϭ 0.02). The mean weight of 14 day fetuses from embryos of PMSGstimulated females was 1.07 Ϯ 0.08 g and the weight of fetuses from embryos of non-stimulated females was 1.00 Ϯ 0.04 g. These values were not significantly different from each other. The weight of 14 day fetuses from undisturbed females is 1.60 Ϯ 0.05 g (Klein and Bavister, unpublished) . Even though the fetuses were small, no gross fetal abnormalities were observed.
Discussion
Hamster morulae and blastocysts produced by females superstimulated with PMSG have fewer cell numbers after culture and are less viable upon transfer than embryos recovered from non-stimulated females. In this study, it was not possible to determine what caused the loss of developmental competence of the non-viable embryos. However, the presence of circulating PMSG in the experimental donor females was the only difference from the control females; therefore, gonadotrophin stimulation was most likely a significant factor.
Recruitment of follicles using PMSG produces a cascade of hormonal and physiological events that alter the intrafollicular, oviductal and uterine environments. In this study, one-cell embryos were flushed from oviducts 10 h post-egg activation. Therefore, exposure to a PMSG-induced environment was limited to the 4 days of follicular development and 10 h in the oviduct.
Superovulated oocytes mature in an environment that is very different from that of unstimulated oocytes (Foote and Ellington, 1988) . The developing follicle has two components, the somatic and the germinal. The somatic portion, during the pre-ovulatory phase of development, undergoes growth and differentiation (Richards, 1980) . In the rat, histological analyses revealed large differences between the maturing follicles of stimulated ovaries compared to non-stimulated ovaries (Szoltys et al., 1994) . PMSG treatment hyper-stimulated the developing theca interna cells of the follicle and increased ovarian androgen production; this was followed by granulosa cell degeneration. In addition, higher than normal oestradiol and lower than normal progesterone concentrations were observed in the ovary. It has been suggested that these changes in the follicular microenvironment cause abnormalities in the developing germinal component of the follicle (Szoltys et al., 1994) .
PMSG has a long half-life and, in addition to inducing superovulation, is known to have LH-like activity (Schams et al., 1978) . Normally, the oocyte remains unchanged within the follicle during the pre-ovulatory phase, and only undergoes major changes after the LH surge (Richards, 1980) . In the presence of PMSG, the oocyte has a constant premature exposure to LH (Foote and Ellington, 1988) . In PMSG-treated sheep, a significant portion of oocytes showed premature activation. This premature activation of the oocyte produces abnormalities in protein patterns in a significant portion of follicular oocytes, indicating that some oocytes will be aged at ovulation (Moor et al., 1985) .
Hamster embryos collected from super-stimulated females in the present study were derived from oocytes that developed in follicles altered by the presence of PMSG. Due to PMSG stimulation, sustained LH levels elevate plasma progesterone and oestradiol concentrations in the hamster (Greenwald, 1976) and cause a breakdown in the granulosa and thecal cell layers (Hubbard and Greenwald, 1985) .
The most significant observation in this study was the negative effect of PMSG on post-transfer viability. Previous studies have examined the effects of PMSG on in-vivo preand post-implantation development within the stimulated female and have demonstrated clearly that the uterus of a PMSG-stimulated female has a negative effect on development (Miller and Armstrong, 1981a,b; Walton and Armstrong, 1981; Walton et al., 1982; Ertzeid et al., 1993; Paulson et al., 1997) . Gates (1956) transferred morulae and blastocysts from PMSG-727 and non-stimulated mice into non-stimulated females and found no significant difference between the number of viable fetuses produced from either group. Embryos in the present study developed post-transfer in a non-stimulated uterine environment. Thompson et al. (1995) found no differences between in-vitro pre-implantation development of pronucleate and two-cell embryos recovered from stimulated and nonstimulated ewes, but did observe a significant reduction in the post-transfer survival of embryos recovered from PMSGstimulated donors. From the study by Thompson et al. (1995) and the present one, in which embryos were removed from the PMSG-induced environment and transferred as morulae and blastocysts into non-stimulated recipient females, it can be concluded that the PMSG effect was at oocyte maturation or during the embryos' brief exposure to the oviduct. Defects incurred at these early levels of development are manifested much later as reduced fetal viability. The defect in the oocyte is unknown. It does not exist in all oocytes recovered from PMSG-stimulated donors since, in this study, fetuses survived to late gestational stages.
Chromosomal abnormalities may account for reduced viability of embryos from super-stimulated females. Cytogenetic abnormalities have been observed in eggs and embryos of a number of species stimulated with PMSG (King, 1985) . In humans, stimulation with gonadotrophin-releasing hormone (GnRH) and pure FSH produced a significant proportion of oocytes with abnormal metaphase II chromosomal configurations and poor quality embryos exhibited numerous nuclear abnormalities (Wojcik et al., 1995) . However, in the hamster, Sengoku and Dukelow (1988) found no effect of PMSG on the incidence of chromosomal aberrations.
In the present study, the number of cells was significantly reduced in embryos exposed to PMSG. The average number of cells in a hamster blastocyst (in vivo) immediately prior to implantation is 24 (Gonzales, 1993) . Reduced embryonic cell numbers have been observed in cultured embryos (Giles and Foote, 1995) . In-vitro culture conditions simply cannot adequately substitute for the reproductive tract of the female. The reduced cell number of embryos from PMSG-stimulated females was an effect of PMSG treatment, since embryos from non-stimulated females were collected and cultured under identical conditions but had significantly higher numbers of cells. Differences in cell number could be due to differences in ovulation times of the group in which ovulation had been stimulated, hence a change in the timing of embryonic development. Differences in cleavage rates were observed between stimulated and non-stimulated in-vivo mouse embryos (Allen and McLaren, 1971 ). This does not seem to be the case in hamster embryos, since variability in cell number between the two groups was the same. However, differences may be obscured, since observations were made at static time points, timing of development through use of videomicroscopy may show differences in cleavage rates between the two groups. Reduced total embryonic cell numbers indicate that fewer cells will differentiate into the inner cell mass, reducing the potential for producing a viable fetus.
Although a significantly greater percentage of one-cell embryos from PMSG-stimulated females remained at the one-cell stage during culture (3%) compared to embryos from nonstimulated females (0.2%), this was a numerically small difference. Fertilization defects may account for the arrested development. However, one-cell embryos selected for culture had the overt signs of normal fertilization (two polar bodies and two pronuclei). Possibly, these were aged eggs at fertilization and were unable to complete the first cleavage division. Once cleavage was initiated, PMSG stimulation did not affect the morphological appearance of one-cell embryos developing to the morula and blastocyst stages in vitro. Development to the eight-cell, morula and blastocyst stages was very similar between embryos from PMSG-and non-stimulated female hamsters. In contrast, studies in mice (Lehtonen and Kankondi, 1987; Schmidt et al., 1989; Ertzeid and Storeng, 1992; Ertzeid et al., 1993) and rats (Walton et al., 1983; Evans and Armstrong, 1984; Leveille and Armstrong, 1989) showed abnormalities in pre-implantation embryo development after PMSG stimulation. However, embryos obtained from PMSGand non-stimulated rabbits had equal developmental potential (Maurer et al., 1968; Foote and Ellington, 1988) . These discrepancies may be explained by effects of PMSG on pre-implantation embryo development being dependent upon a number of factors, including species and/or strain (Schmidt et al., 1989) , dosage (Maudlin and Fraser, 1977; Walton and Armstrong, 1981; Evans and Armstrong, 1984) , site of injection (Lehtonen and Kankondi, 1987) and the exposure time in the reproductive tract (Miller and Armstrong, 1981a,b; Ertzeid and Storeng, 1992) .
Embryos produced from PMSG-stimulated donors are different from embryos from non-stimulated donors. These embryos apparently develop normally in vitro yet lose their developmental competence post-transfer. Embryos from PMSG-stimulated donors have reduced cell numbers which may account for the increased post-transfer embryo/fetal mortality. These findings may offer some explanation for the low viability of human embryos produced from oocytes recruited by gonadotrophin stimulation protocols.
This study invokes caution when using super-stimulated females to produce high numbers of embryos to conduct factorial experiments, especially for the development of new culture media formulations. It is assumed these media have been optimized for 'normal embryo development in vitro'. This study points out the inherent error of that assumption, because embryos collected from super-stimulated females are not normal. Ideally, media should be developed using embryos from naturally ovulating females. At the least, media formulations should be tested using embryos from both super-and non-stimulated females and verified through embryo transfer so that differences between these two classes of embryos can be examined.
